Treatment for Skin Picking (Excoriation Disorder)
Cognitive-behavioral therapy with habit reversal training should be the first-line treatment for skin picking disorder, with N-acetylcysteine (1200-3000 mg/day) or SSRIs as effective pharmacologic options when psychotherapy alone is insufficient. 1, 2
Treatment Algorithm
First-Line Approach: Behavioral Therapy
Habit reversal therapy (HRT) represents the most effective evidence-based treatment for skin picking disorder 3, 4. This behavioral intervention directly targets the repetitive picking behaviors through awareness training, competing response development, and stimulus control techniques.
Pharmacologic Treatment Options
When behavioral therapy is inadequate or unavailable, pharmacologic intervention becomes necessary:
N-Acetylcysteine (NAC): Strongest Evidence
- Dosing: 1200-3000 mg/day for 12 weeks
- A randomized controlled trial demonstrated that 47% of patients receiving NAC were "much or very much improved" compared to only 19% on placebo (p=0.03) 2
- NAC works by restoring extracellular glutamate concentration in the nucleus accumbens, targeting the glutamatergic dysfunction underlying compulsive behaviors
- Well-tolerated with minimal side effects
- This represents the highest quality pharmacologic evidence available 2
SSRIs: Most Commonly Used
Selective serotonin reuptake inhibitors show the most promising results among traditional psychiatric medications and are increasingly used in combination with psychotherapy 1. The evidence supports their use particularly when:
- Comorbid depression or anxiety is present
- NAC has been ineffective or not tolerated
- Patient prefers established psychiatric medications
Alternative Pharmacologic Options
When first-line treatments fail, consider:
- Antipsychotics (olanzapine, aripiprazole): Often combined with antidepressants 1, 3
- Naltrexone: Opioid antagonist targeting reward pathways 1
- Other agents: Lamotrigine, topiramate, memantine, mirtazapine have limited evidence 1
Clinical Decision Framework
- Start with behavioral therapy (HRT) as monotherapy if accessible
- Add NAC if behavioral therapy provides insufficient improvement after 8-12 weeks
- Consider SSRIs if comorbid mood/anxiety disorders present or NAC ineffective
- Combine psychotherapy + pharmacotherapy for moderate-to-severe cases from the outset
- Reserve augmentation strategies (antipsychotics, naltrexone) for treatment-resistant cases
Important Caveats
Diagnostic Clarity: Skin picking disorder is distinct from OCD, though both involve repetitive behaviors. The guidelines explicitly note that skin picking should not be diagnosed as OCD 5. This distinction matters because treatment approaches differ—SPD responds better to glutamatergic agents like NAC, while OCD typically requires higher-dose SSRIs or clomipramine.
Self-Monitoring Limitations: Recent evidence shows that self-monitoring alone (even with placebo pills) produces minimal benefit beyond baseline awareness, with only 3% reduction in urges and 6 minutes less picking per day 6. This underscores the need for active interventions rather than passive tracking.
Neurobiological Basis: Neuroimaging reveals frontostriatal circuit dysfunction with hypoactivity in the anterior cingulate cortex and dorsal striatum 7. This explains why glutamatergic modulation (NAC) and habit-focused behavioral interventions targeting motor circuits are particularly effective.
Interdisciplinary Approach: Given the visible dermatologic manifestations, collaboration between dermatology and psychiatry optimizes outcomes 4. Dermatologists should recognize the psychiatric nature of the disorder and refer appropriately rather than focusing solely on wound care.